**Question:** BRAF gene mutation is seen in

A. Colorectal cancer
B. Lung cancer
C. Melanoma
D. Thyroid cancer

**Correct Answer:** C. Melanoma

**Core Concept:**

The BRAF gene is part of the RAS/RAF/MEK/ERK signaling pathway, which plays a crucial role in regulating cell growth, differentiation, and survival. Mutations in this pathway are linked to the development of various cancers, particularly in the context of oncogenes and tumor suppressor genes. The RAS/RAF/MEK/ERK pathway is composed of a series of proteins that work together to transmit signals from cell surface receptors to the nucleus.

**Why the Correct Answer is Right:**

The BRAF gene mutation is primarily associated with melanoma, a malignant tumor of melanocytes (pigment-producing cells) in the skin. The V600E mutation is the most common BRAF mutation and is found in approximately 50-60% of melanomas. This mutation leads to constitutive activation of the RAS/RAF/MEK/ERK pathway, resulting in uncontrolled cell growth and proliferation.

**Why Each Wrong Option is Incorrect:**

A. Colorectal cancer: Though BRAF mutations can be found in colorectal cancer, the most common mutation is the BRAF V600K variant, which is less common than the V600E mutation in melanomas.
B. Lung cancer: The most common mutations in lung cancer are EGFR and ALK gene mutations, not BRAF V600E.
D. Thyroid cancer: BRAF mutations are less common in thyroid cancer compared to other driver mutations like RAS or RET.

**Clinical Pearl:**

Understanding the association between BRAF gene mutations and specific types of cancer can help guide clinical decision-making, particularly in the context of targeted therapy options. For instance, when BRAF V600E mutation is detected in a patient with melanoma, treatment with BRAF and MEK inhibitors can lead to improved response rates and overall survival compared to standard therapies.